Aclaris Therapeutics to Present at Upcoming Investor Conferences in June

MALVERN, Pa., May 31, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that Dr. Neal Walker, President & Chief Executive Officer, will present at three upcoming investor conferences in June.

Jefferies 2016 Healthcare Conference
June 8, 2016, 3:00 p.m. EDT
Grand Hyatt, New York City

William Blair’s 35th Annual Growth Stock Conference
June 15, 2016, 9:20 a.m. CDT
Four Seasons Hotel, Chicago

JMP Securities Life Sciences Conference
June 22, 2016, 11:30 a.m. EDT
The St. Regis, New York City

A live audio webcast of the Aclaris presentations may be accessed by visiting the “Investors” section of the Company’s website at A replay of the webcasts will be archived on the Aclaris website for 14 days following the presentation dates.

About Aclaris
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology. Aclaris Therapeutics, Inc. is based in Malvern, Pennsylvania and more information can be found by visiting the company’s website at

Contact: Aclaris Contact Frank Ruffo Chief Financial Officer 484-324-7933 Investor Contact Patricia L. Bank Westwicke Partners Managing Director 415-513-1284 Media Contact Mike Beyer Sam Brown, Inc. 312-961-2502

Source:Aclaris Therapeutics, Inc.